seen from Malaysia
seen from China
seen from United States
seen from China
seen from Russia
seen from Italy
seen from Portugal
seen from United States
seen from Indonesia
seen from Maldives
seen from China
seen from Singapore
seen from United States
seen from United States
seen from United States
seen from United States
seen from China
seen from China
seen from China
seen from China
Mallinckrodt to buy Sucampo for about $840 million Drugmaker Mallinckrodt said on Tuesday it would buy Sucampo Pharmaceuticals for about $ 840 million, excluding debt, to gain access to its constipation drug, Amitiza. Mallinckrodt said it offered $ 18 per Sucampo share held, representing a premium of about 6 perce... Health Care
